Risk Stratification, Treatment Selection, and Transplant Eligibility in Multiple Myeloma: A Qualitative Study of the Perspectives and Self-Reported Practices of Oncologists | Zendy

Thomas W. LeBlanc | Zendy; A. G. Howson | Zendy; Wendy Turell | Zendy; P.W. Sheldon | Zendy; Susan C. Locke | Zendy; Sascha A. Tuchman | Zendy; Cristina Gasparetto | Zendy; S. Kaura | Zendy; Zeba Khan | Zendy; Amy P. Abernethy | Zendy

Open Access

Risk Stratification, Treatment Selection, and Transplant Eligibility in Multiple Myeloma: A Qualitative Study of the Perspectives and Self-Reported Practices of Oncologists

Author(s) -

Thomas W. LeBlanc,

A. G. Howson,

Wendy Turell,

P.W. Sheldon,

Susan C. Locke,

Sascha A. Tuchman,

Cristina Gasparetto,

S. Kaura,

Zeba Khan,

Amy P. Abernethy

Publication year - 2016

Publication title -

current oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.053

H-Index - 51

eISSN - 1718-7729

pISSN - 1198-0052

DOI - 10.3747/co.23.3298

Subject(s) - medicine , referral , psychosocial , psychological intervention , family medicine , transplantation , multiple myeloma , qualitative research , nursing , psychiatry , social science , sociology

Since the early 2000s, treatment options for multiple myeloma have rapidly expanded, adding significant complexity to the management of this disease. To our knowledge, no systematic qualitative research on clinical decision-making in multiple myeloma has been published. We sought to characterize how physicians view and implement guidelines and incorporate novel approaches into patient care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research